GLP-1 drugs: what Pennsylvania Medical Assistance paid

Q: Does a paid prescription mean Medical Assistance covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Medical Assistance shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Medical Assistance's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Medical Assistance’s payment record shows

In 2026Q1, the product Medical Assistance paid for most often was Ozempic®, at 39,722 prescriptions¹⁹ of the 53,418 to 53,625^{1,7,13,19,25,37,43} across all 8 products, or 74 percent of the published count.

Medical Assistance itself reimbursed at least $51,197,087 for these products in the quarter, about $959 per prescription. Pharmacies were paid $54,660,964 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Ozempic®, at about $976.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Medical Assistance finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Medical Assistance. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Medical Assistance paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Medical Assistance paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both3,397 managed care, 37 direct	at least 3,434¹	6%	$3,130,101	$3,627,162	$912
tirzepatideMounjaro®	Both6,184 managed care, 190 direct	at least 6,374⁷	12%	$5,818,822	$6,897,690	$913
semaglutideWegovy®	Both2,326 managed care, 54 direct	at least 2,380¹³	4%	$2,196,770	$3,130,780	$923
semaglutideOzempic®	Both39,372 managed care, 350 direct	at least 39,722¹⁹	74%	$38,786,580	$39,690,333	$976
semaglutideRybelsus®	Both1,014 managed care, 11 direct	at least 1,025²⁵	2%	$989,758	$1,030,415	$966
liraglutideSaxenda®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	370³⁷	<1%	$235,884	$235,884	$638
liraglutideliraglutide (generic)	Both	at least 90⁴³	<1%	$39,171	$48,700	$435

Medical Assistance publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 370 against 6,813. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 19.5 to 19.6 prescriptions per thousand people enrolled in Medical Assistance, on an average of 2,734,998 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 6 of the 168 product-quarters it holds a row for here, which is 4 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Medical Assistance pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Medical Assistance paid for each product, quarter by quarter

Prescriptions Medical Assistance paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	at least 84 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴At least$74,489 paid	at least 2,320 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$2,182,465 paid	at least 6,662 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$6,607,208 paid	at least 13,432 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$13,511,083 paid	at least 22,282 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$22,437,194 paid	at least 32,778 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$33,994,401 paid	at least 47,381 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$49,415,407 paid	at least 59,567 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$62,649,721 paid	at least 67,535 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$72,112,528 paid	at least 3,434 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$3,130,101 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 100 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$64,838 paid	at least 494 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$345,423 paid	at least 1,398 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$1,044,000 paid	at least 2,168 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$1,690,276 paid	at least 3,086 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$2,437,936 paid	at least 3,970 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$3,317,764 paid	at least 4,323 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$3,770,081 paid	at least 4,459 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$4,075,523 paid	at least 5,295 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$4,910,756 paid	at least 5,949 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$5,548,216 paid	at least 6,847 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$6,529,680 paid	at least 8,384 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$8,019,653 paid	at least 9,824 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$9,375,925 paid	at least 10,927 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$10,421,623 paid	at least 6,374 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$5,818,822 paid
semaglutideWegovy®range 19,292 to 63,904	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld5 of 5 product codes withheld	at least 20 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld¹⁷At least$8,633 paid	at least 32 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld¹⁷At least$8,637 paid	at least 37 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹⁷At least$9,994 paid	at least 15 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹⁷At least$3,682 paid	at least 11,038 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$14,069,684 paid	24,197 paid prescriptions in the quarter (2023Q2)¹⁶Count$31,025,672 paid	19,292 paid prescriptions in the quarter (2023Q3)¹⁶Count$25,201,790 paid	at least 17,384 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁶At least$23,015,088 paid	at least 19,250 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld¹⁵At least$25,638,063 paid	35,288 paid prescriptions in the quarter (2024Q2)¹⁵Count$46,656,161 paid	46,905 paid prescriptions in the quarter (2024Q3)¹⁵Count$61,702,579 paid	50,492 paid prescriptions in the quarter (2024Q4)¹⁵Count$66,271,502 paid	58,684 paid prescriptions in the quarter (2025Q1)¹⁴Count$77,008,525 paid	62,895 paid prescriptions in the quarter (2025Q2)¹⁴Count$82,472,114 paid	63,904 paid prescriptions in the quarter (2025Q3)¹⁴Count$83,632,527 paid	61,848 paid prescriptions in the quarter (2025Q4)¹⁴Count$81,446,669 paid	at least 2,380 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$2,196,770 paid
semaglutideOzempic®range 51,302 to 52,378	at least 4,049 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$3,413,837 paid	at least 6,897 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$5,956,458 paid	at least 9,410 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$8,226,691 paid	at least 11,345 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$9,902,289 paid	at least 5,287 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$4,430,393 paid	at least 4,879 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$4,096,705 paid	at least 4,478 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$3,455,274 paid	at least 4,276 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$3,070,587 paid	at least 5,283 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$3,773,055 paid	at least 6,196 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$4,387,619 paid	at least 6,358 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$4,712,830 paid	at least 6,140 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$4,936,284 paid	at least 20,940 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$19,723,248 paid	at least 41,152 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$39,999,893 paid	51,302 paid prescriptions in the quarter (2024Q3)²¹Count$50,009,238 paid	52,378 paid prescriptions in the quarter (2024Q4)²¹Count$51,113,074 paid	at least 55,909 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$56,316,143 paid	at least 58,528 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$58,860,480 paid	at least 60,625 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$60,591,183 paid	at least 59,684 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$59,539,759 paid	at least 39,722 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$38,786,580 paid
semaglutideRybelsus®	at least 182 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$129,649 paid	at least 258 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$196,956 paid	at least 343 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$267,041 paid	at least 360 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$281,260 paid	at least 432 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$351,435 paid	at least 527 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$440,555 paid	at least 539 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$460,295 paid	at least 646 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$543,904 paid	at least 760 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$668,831 paid	at least 800 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$686,612 paid	at least 885 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$786,163 paid	at least 903 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$812,778 paid	at least 905 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$834,019 paid	at least 926 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$880,855 paid	at least 910 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$871,280 paid	at least 857 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$831,211 paid	at least 805 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$807,704 paid	at least 721 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$713,539 paid	at least 758 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$738,466 paid	at least 707 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$709,285 paid	at least 1,025 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$989,758 paid
liraglutideSaxenda®range 13 to 3,246	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	13 paid prescriptions in the quarter (2021Q2)³⁶Count$13,045 paid	16 paid prescriptions in the quarter (2021Q3)³⁶Count$17,603 paid	26 paid prescriptions in the quarter (2021Q4)³⁶Count$17,184 paid	28 paid prescriptions in the quarter (2022Q1)³⁵Count$25,504 paid	31 paid prescriptions in the quarter (2022Q2)³⁵Count$29,251 paid	41 paid prescriptions in the quarter (2022Q3)³⁵Count$30,700 paid	36 paid prescriptions in the quarter (2022Q4)³⁵Count$33,842 paid	at least 690 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld³⁴At least$788,437 paid	2,678 paid prescriptions in the quarter (2023Q2)³⁴Count$3,151,352 paid	3,246 paid prescriptions in the quarter (2023Q3)³⁴Count$3,625,334 paid	1,294 paid prescriptions in the quarter (2023Q4)³⁴Count$1,564,338 paid	at least 725 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³³At least$831,045 paid	1,199 paid prescriptions in the quarter (2024Q2)³³Count$1,470,859 paid	at least 1,026 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³³At least$1,245,296 paid	at least 841 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³³At least$1,046,603 paid	at least 632 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³²At least$785,316 paid	at least 456 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³²At least$569,725 paid	at least 313 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³²At least$392,011 paid	141 paid prescriptions in the quarter (2025Q4)³²Count$173,621 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®range 370 to 7,551	6,813 paid prescriptions in the quarter (2021Q1)⁴²Count$6,433,399 paid	6,674 paid prescriptions in the quarter (2021Q2)⁴²Count$6,411,423 paid	6,114 paid prescriptions in the quarter (2021Q3)⁴²Count$5,884,661 paid	5,538 paid prescriptions in the quarter (2021Q4)⁴²Count$5,302,267 paid	6,007 paid prescriptions in the quarter (2022Q1)⁴¹Count$6,016,726 paid	6,202 paid prescriptions in the quarter (2022Q2)⁴¹Count$6,346,313 paid	6,160 paid prescriptions in the quarter (2022Q3)⁴¹Count$6,095,556 paid	6,498 paid prescriptions in the quarter (2022Q4)⁴¹Count$6,392,261 paid	7,551 paid prescriptions in the quarter (2023Q1)⁴⁰Count$7,598,297 paid	7,225 paid prescriptions in the quarter (2023Q2)⁴⁰Count$7,150,187 paid	6,884 paid prescriptions in the quarter (2023Q3)⁴⁰Count$6,693,282 paid	at least 6,442 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$6,207,711 paid	5,287 paid prescriptions in the quarter (2024Q1)³⁹Count$3,824,330 paid	3,653 paid prescriptions in the quarter (2024Q2)³⁹Count$2,623,747 paid	at least 1,829 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$1,304,974 paid	at least 1,382 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$1,014,683 paid	at least 764 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$493,532 paid	at least 286 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$195,610 paid	393 paid prescriptions in the quarter (2025Q3)³⁸Count$284,484 paid	at least 434 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$312,056 paid	370 paid prescriptions in the quarter (2026Q1)³⁷Count$235,884 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	at least 213 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$139,637 paid	at least 143 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$83,205 paid	at least 246 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$140,125 paid	at least 283 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$161,125 paid	at least 284 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$163,047 paid	at least 321 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$209,280 paid	at least 90 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$39,171 paid

What this page cannot tell you

Whether Medical Assistance covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Pennsylvania in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, PA
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "878"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, PA
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "16078"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, PA
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "6644"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, PA
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "84"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, PA
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "product_name": "product_name like ZEPBOUND%, state PA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, PA
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "product_name": "product_name like ZEPBOUND%, state PA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, PA
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "1308"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, PA
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 1", "suppression_used": "false", "number_of_prescriptions": "2177"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, PA
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1315"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, PA
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1029"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, PA
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "197"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, PA
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "product_name": "product_name like MOUNJARO%, state PA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, PA
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "750"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, PA
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "19983"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, PA
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "14232"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, PA
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "9314"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, PA
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "24"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, PA
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1MG", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, PA
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "14096"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, PA
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "22679"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, PA
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "24531"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, PA
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2487"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, PA
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2830"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, PA
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "7023"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, PA
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "473"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, PA
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "367"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, PA
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "372"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, PA
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "383"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, PA
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "289"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, PA
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "138"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, PA
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, PA
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "632"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, PA
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "1188"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, PA
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "3206"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, PA
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "41"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, PA
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "26"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, PA
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "195"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, PA
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "472"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, PA
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "3210"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, PA
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "4577"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, PA
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "4112"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, PA
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "Victoza 6M", "suppression_used": "false", "number_of_prescriptions": "4709"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, PA
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state PA, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "PA", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "24"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, PA
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state PA, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "135"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, PA
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state PA, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "132"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, PA
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state PA, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "product_name": "product_name like LIRAGLUTID%, state PA, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, PA
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state PA, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "product_name": "product_name like LIRAGLUTID%, state PA, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, PA
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state PA, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "PA", "product_name": "product_name like LIRAGLUTID%, state PA, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 42 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 6 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Medical Assistance covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.